A friendly and supportive community, register today. Our forums use a separate account system.

Australia News in brief: Nexalis completes Phase 1 IRX-616a dosing

Thread starter Cannabiz
Start date Today at 2:28am

Today at 2:28am

Nexalis Therapeutics – formerly InhaleRx – has completed dosing in its Phase 1 clinical trial of […]

The post News in brief: Nexalis completes Phase 1 IRX-616a dosing appeared first on Cannabiz.

Continue reading...

Click to expand...

Similar Discussions (Automatically Generated)

Article

Australia News in brief: Nexalis advances IRX-616a trial

Replies: 0

Views: 45

20th Apr, 2026

Cannabiz

Article

Australia Nexalis outlines 2026 plan as IRX shares jump 35%

Replies: 0

Views: 77

16th Feb, 2026

Cannabiz

Article

Australia Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery; Neurotech reassures ASX

Replies: 0

Views: 29

29th Apr, 2026

Cannabiz

Article

Australia News in brief: 150 applications for council CEO role; Rua sends NZ genetics to Canada; Argent completes pet business deal

Replies: 0

Views: 42

15th Apr, 2026

Cannabiz

Article

Australia News in brief: IRX CEO takes shares over salary

Replies: 0

Views: 187

22nd Oct, 2025

Cannabiz

Share:

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Top